Antitumor efficacy of 90Y-NM600 targeted radionuclide therapy and PD-1 blockade is limited by regulatory T cells in murine prostate tumors
暂无分享,去创建一个
D. McNeel | B. Bednarz | J. Engle | R. Hernandez | J. Weichert | Hemanth K. Potluri | J. Grudzinski | I. Marsh | E. Aluicio‐Sarduy | C. Ferreira | O-Seo Kwon | Christopher F. Massey